Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency

J Control Release. 2012 Oct 10;163(1):2-9. doi: 10.1016/j.jconrel.2012.07.028. Epub 2012 Jul 27.

Abstract

To evaluate the tumor targeting efficiency of self-assembled polymeric nanoparticles, four glycol chitosan nanoparticles (CNPs) with different degrees of hydrophobic substitution were prepared by coupling 7.5, 12, 23, and 35 wt.% of 5β-cholanic acid to hydrophilic glycol chitosan polymer (GC). The sizes and zeta-potentials of different CNPs in aqueous condition were not significantly different, but their stability and deformability were greatly dependent upon the degree of substitution (DS) of 5β-cholanic acid. With an increase in hydrophobicity, CNPs became more stable and rigid, as characterized by SDS-PAGE and filtration tests. To compare with CNPs, linear GC and polystyrene nanoparticles (PSNPs) were employed as controls. In vivo tumor accumulation of Cy5.5-labeled linear GC, polystyrene nanoparticles (PSNPs) and CNPs were monitored in flank tumors and liver tumor-bearing mice models using near-infrared fluorescence (NIRF) imaging systems. CNPs displayed higher tumor accumulation than GC and PSNPs via the enhanced permeability and retention (EPR) effect. Interestingly, CNPs containing 23 wt.% of 5β-cholanic acid (CNP-23%) showed the highest tumor-targeting efficiency compared to other CNPs. As exemplified in this study, the stability of CNP-23% is better than CNP-7.5% and CNP-12% containing 7.5 wt.% and 12 wt.% of 5β-cholanic acid, respectively, and the deformability of CNP-23% is better than that of CNP-35% containing 35 wt.% of 5β-cholanic acid. We proposed that the superior tumor-targeting efficiency of CNP-23% is mainly due to their balanced stability and deformability in vivo. This study demonstrates that the degree of hydrophobic substitution of self-assembled nanoparticles could determine their stability and deformability. Importantly, they were founded to be the key factors which affect their tumor-targeting efficiency in vivo, and so that these factors should be highly considered during developing nanoparticles for tumor-targeted imaging or drug delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbocyanines / administration & dosage
  • Chitosan / administration & dosage
  • Chitosan / chemistry*
  • Cholic Acids / chemistry
  • Coloring Agents / administration & dosage
  • Drug Carriers / administration & dosage
  • Drug Carriers / chemistry*
  • Drug Stability
  • HT29 Cells
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Liver Neoplasms / metabolism*
  • Male
  • Mice
  • Mice, Nude
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*

Substances

  • CY5.5 cyanine dye
  • Carbocyanines
  • Cholic Acids
  • Coloring Agents
  • Drug Carriers
  • glycol-chitosan
  • Chitosan
  • cholanic acid